Booth Bruce

Director at Sionna Therapeutics, Inc. · on record since Feb 10, 2025
Director at Kymera Therapeutics, Inc. · on record since Apr 16, 2026
Director at Larimar Therapeutics, Inc. · on record since Jun 26, 2014
10% owner at Larimar Therapeutics, Inc. · on record since Jan 12, 2015
Director at MED GEN INC · on record since Mar 28, 2017
Director at Cogent, Inc. · on record since Mar 28, 2018
Director at Dianthus Therapeutics, Inc. /DE/ · on record since Jun 27, 2018
Director at IT&E INTERNATIONAL GROUP · on record since Jun 25, 2018
Director at Vigil Neuroscience, Inc. · on record since Jan 11, 2022

Insider trading activity of Booth Bruce

Transactions on record: 374; since Jun 26, 2014

Open-market buys: 6; $37.7M

Open-market sells: 251; $150M

Companies traded: 8; last filing Jul 2, 2026

Figures computed from official regulatory filings — methodology.

Companies where Booth Bruce has traded

Kymera Therapeutics, Inc.223 tx · $127.9M · Jul 2, 2026
Sionna Therapeutics, Inc.60 tx · $23.2M · Jun 18, 2026
Vigil Neuroscience, Inc.31 tx · $7.8M · Aug 5, 2025
IT&E INTERNATIONAL GROUP13 tx · $15M · Jun 8, 2023
Dianthus Therapeutics, Inc. /DE/11 tx · $10.3M · Jun 30, 2022
Cogent, Inc.16 tx · $1.3M · Jul 6, 2020
MED GEN INC5 tx · $3M · Jun 28, 2018
Larimar Therapeutics, Inc.15 tx · $70K · Jan 5, 2018

Track record of Booth Bruce

Statistical track record

Free

Open-market buys: 6

Last buy: Feb 10, 2025

Win rates and median returns are available with a free account (5 insiders/month).

Create a free account

Transaction history of Booth Bruce

Co-insiders of Booth Bruce

This page republishes public regulatory disclosures. Concerned by this data? Exercise your right to object →

Company	Filed	Type	Qty	Price	Value · USD	Src
Kymera Therapeutics, Inc.	Jul 2, 2026	Sell	-2,698	107.76 USD	—	SEC
Kymera Therapeutics, Inc.	Jul 2, 2026	Sell	-770	105.78 USD	—	SEC
Kymera Therapeutics, Inc.	Jul 2, 2026	Sell	-1,078	110.67 USD	—	SEC
Kymera Therapeutics, Inc.	Jul 2, 2026	Sell	-5,549	105.78 USD	—	SEC
Kymera Therapeutics, Inc.	Jul 2, 2026	Sell	-130	111.20 USD	—	SEC
Kymera Therapeutics, Inc.	Jul 2, 2026	Sell	-1,104	109.75 USD	—	SEC
Kymera Therapeutics, Inc.	Jul 2, 2026	Sell	-2,133	106.63 USD	—	SEC
Kymera Therapeutics, Inc.	Jul 2, 2026	Sell	-14,798	106.63 USD	—	SEC
Kymera Therapeutics, Inc.	Jul 2, 2026	Sell	-934	111.20 USD	—	SEC
Kymera Therapeutics, Inc.	Jul 2, 2026	Sell	-7,723	110.67 USD	—	SEC
Kymera Therapeutics, Inc.	Jul 2, 2026	Sell	-1,498	108.28 USD	—	SEC
Kymera Therapeutics, Inc.	Jul 2, 2026	Sell	-7,968	109.75 USD	—	SEC
Kymera Therapeutics, Inc.	Jul 2, 2026	Sell	-10,848	108.28 USD	—	SEC
Kymera Therapeutics, Inc.	Jul 2, 2026	Sell	-19,419	107.76 USD	—	SEC
Kymera Therapeutics, Inc.	Jun 30, 2026	Sell	-1,199	110.67 USD	—	SEC
Kymera Therapeutics, Inc.	Jun 30, 2026	Sell	-10,658	108.28 USD	—	SEC
Kymera Therapeutics, Inc.	Jun 30, 2026	Sell	-7,833	109.75 USD	—	SEC
Kymera Therapeutics, Inc.	Jun 30, 2026	Sell	-157	111.20 USD	—	SEC
Kymera Therapeutics, Inc.	Jun 30, 2026	Sell	-1,239	109.75 USD	—	SEC
Kymera Therapeutics, Inc.	Jun 30, 2026	Sell	-907	111.20 USD	—	SEC
Kymera Therapeutics, Inc.	Jun 30, 2026	Sell	-7,602	110.67 USD	—	SEC
Kymera Therapeutics, Inc.	Jun 30, 2026	Sell	-1,688	108.28 USD	—	SEC
Kymera Therapeutics, Inc.	Jun 25, 2026	Sell	-173	99.98 USD	—	SEC
Kymera Therapeutics, Inc.	Jun 25, 2026	Sell	-2,011	108.83 USD	—	SEC
Kymera Therapeutics, Inc.	Jun 25, 2026	Sell	-223	126.71 USD	—	SEC

Company	Filed	Type	Qty	Price	Value · USD	Src
Kymera Therapeutics, Inc.	Jul 2, 2026	Sell	-2,698	107.76 USD	—	SEC
Kymera Therapeutics, Inc.	Jul 2, 2026	Sell	-770	105.78 USD	—	SEC
Kymera Therapeutics, Inc.	Jul 2, 2026	Sell	-1,078	110.67 USD	—	SEC
Kymera Therapeutics, Inc.	Jul 2, 2026	Sell	-5,549	105.78 USD	—	SEC
Kymera Therapeutics, Inc.	Jul 2, 2026	Sell	-130	111.20 USD	—	SEC
Kymera Therapeutics, Inc.	Jul 2, 2026	Sell	-1,104	109.75 USD	—	SEC
Kymera Therapeutics, Inc.	Jul 2, 2026	Sell	-2,133	106.63 USD	—	SEC
Kymera Therapeutics, Inc.	Jul 2, 2026	Sell	-14,798	106.63 USD	—	SEC
Kymera Therapeutics, Inc.	Jul 2, 2026	Sell	-934	111.20 USD	—	SEC
Kymera Therapeutics, Inc.	Jul 2, 2026	Sell	-7,723	110.67 USD	—	SEC
Kymera Therapeutics, Inc.	Jul 2, 2026	Sell	-1,498	108.28 USD	—	SEC
Kymera Therapeutics, Inc.	Jul 2, 2026	Sell	-7,968	109.75 USD	—	SEC
Kymera Therapeutics, Inc.	Jul 2, 2026	Sell	-10,848	108.28 USD	—	SEC
Kymera Therapeutics, Inc.	Jul 2, 2026	Sell	-19,419	107.76 USD	—	SEC
Kymera Therapeutics, Inc.	Jun 30, 2026	Sell	-1,199	110.67 USD	—	SEC
Kymera Therapeutics, Inc.	Jun 30, 2026	Sell	-10,658	108.28 USD	—	SEC
Kymera Therapeutics, Inc.	Jun 30, 2026	Sell	-7,833	109.75 USD	—	SEC
Kymera Therapeutics, Inc.	Jun 30, 2026	Sell	-157	111.20 USD	—	SEC
Kymera Therapeutics, Inc.	Jun 30, 2026	Sell	-1,239	109.75 USD	—	SEC
Kymera Therapeutics, Inc.	Jun 30, 2026	Sell	-907	111.20 USD	—	SEC
Kymera Therapeutics, Inc.	Jun 30, 2026	Sell	-7,602	110.67 USD	—	SEC
Kymera Therapeutics, Inc.	Jun 30, 2026	Sell	-1,688	108.28 USD	—	SEC
Kymera Therapeutics, Inc.	Jun 25, 2026	Sell	-173	99.98 USD	—	SEC
Kymera Therapeutics, Inc.	Jun 25, 2026	Sell	-2,011	108.83 USD	—	SEC
Kymera Therapeutics, Inc.	Jun 25, 2026	Sell	-223	126.71 USD	—	SEC